Full text is available at the source.
Abstract
Lipid nanoparticles (LNPs) are crucial for delivering nucleic acid therapeutics effectively.
- LNP composition significantly influences targeting specific organs and delivery routes.
- Intranasal administration provides a direct pathway to the lungs while minimizing systemic exposure.
- Challenges persist in designing LNPs that can effectively navigate respiratory tract barriers.
Simplified